Sage Journals: Discover world-class research

Retricted access

Review article

First published 2026-1

Assessment of the Potential of GLP-1 Analogs in the Treatment of Addictions: A Literature Review

Isabel Noemi Torres, Maria Jimena Barroso Alverde

Substance Use & Addiction Journal

Free access

Research article

First published 2015-1-1

Synthesis and Evaluation of Optical and PET GLP-1 Peptide Analogues for GLP-1R Imaging

Babak Behnam Azad, Vanessa Rota, Lihai Yu [...]

Molecular Imaging

Retricted access

Research article

First published 2013-1

Type 1 Diabetes Treatment beyond Insulin: Role of GLP-1 Analogs

Lindsay B. Harrison, Pablo F. Mora, Gregory O. Clark [...]

Journal of Investigative Medicine

Open access

Research article

First published 2018-06

The Clinical Impact of GLP-1 Receptor Agonists in Type 2 Diabetes: Focus on the Long-Acting Analogs

Helena W. Rodbard

Diabetes Technology & Therapeutics

Open access

Research article

First published 2026-5

Association Between Preoperative GLP-1 Receptor Analog Use and Postoperative Complications and Mortality Following Lumbar Fusion Surgery

Ahad A. Kesaria, Farhad A. Marzook, James M. Glover [...]

Global Spine Journal

Retricted access

Research article

First published 2014-8

Weekly Exenatide Therapy

Sara J. Micale, Shahabodin Khatounabadi, Michael P. Kane [...]

Journal of Pharmacy Technology

Retricted access

Research article

First published 2010-7

Understanding GLP-1 Analogs and Enhancing Patient Success

Davida F. Kruger, Bruce Bode, Geralyn R. Spollett

The Science of Diabetes Self-Management and Care

Retricted access

Review article

First published 2008-11

Liraglutide,a once-daily human GLP-1 analogue

Michael A Nauck

The British Journal of Diabetes & Vascular Disease

Retricted access

Research article

First published 2026-3

All-Cause Mortality and Health Care Resource Utilization in Patients with Type 1 Diabetes Treated with Glucagon-like Peptide 1 Receptor Agonists/Glucose-Dependent Insulinotropic Polypeptide

Samita Garg, Sarah Kim, Andrew Ford [...]

Diabetes Technology & Therapeutics

Open access

Review article

First published 2014-9

The effects of GLP-1 analogues,DPP-4 inhibitors and SGLT2 inhibitors on the renal system

Guntram Schernthaner, Carl Erik Mogensen, Gerit-Holger Schernthaner

Diabetes & Vascular Disease Research

Search results